Most read article(s)

Research Article
Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception
Sarah Demortiere, Adil Maarouf, Audrey Rico, et al.

August 07, 2023
Article
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Francesc Graus, Alberto Vogrig, Sergio Muñiz-Castrillo, et al.

May 18, 2021
Clinical/Scientific Note
LGI1 Encephalitis and IgG4-Related DiseaseRare Conditions Collide
Aaron Jesuthasan, Tara Barwick, Luke Dixon, et al.

August 15, 2023
Research Article
Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection
Yair Mina, Yoshimi Enose-Akahata, Dima A. Hammoud, et al.

May 05, 2023
Research Article
Electrolyte Imbalance in Anti-LGI1 EncephalitisIt Is Not All in Your Head
Avi Gadoth, Michal Nisnboym Ziv, Yifat Alcalay, et al.

August 17, 2023
Research Article
Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease
Andrew McKeon, Connie Lesnick, Nisa Vorasoot, et al.

August 07, 2023
Research Article
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies
Pedro J. Serrano-Castro, Juan J. Rodríguez-Uranga, Pablo Cabezudo-García, et al.

August 22, 2023
Research Article
EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls
Maria Chiara G. Monaco, Samantha S. Soldan, Chenhe Su, et al.

August 10, 2023
Article
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune EncephalitisReal-world Evidence From the GENERATE Registry
Franziska S. Thaler, Luise Zimmermann, Stefan Kammermeier, et al.

October 01, 2021
Research Article
International Delphi Consensus on the Management of AQP4-IgG+ NMOSDRecommendations for Eculizumab, Inebilizumab, and Satralizumab
Friedemann Paul, Romain Marignier, Jacqueline Palace, et al.

May 31, 2023

Pages